William D. Waddill, who is the SVP and CFO for Calithera Biosciences, has been elected to the Protagonist Therapeutics Inc. Board of Directors, Protagonist announced last week. Read More »
The CVS Health Research Institute recently released the results of a new study that has determined that medication reconciliation programs have decreased hospital readmissions. Read More »
Stent releases drug to reduce scar tissue in coronary arteries after angioplasty. Read More »
Genticel has announced that it has approached Eumedix, a renowned European corporate finance specialist, for strategic advising. Read More »
Provides grant to American Academy of Pediatrics to improve providers' counseling on tobacco and secondhand smoke exposure. Read More »
CVS Pharmacy MinuteClinic locations across the country recently introduced health services and immunizations related to travel to assist patients in their preparation for the travel season. Read More »
Seasoned executive joins Amarin senior management team. Read More »
BELKYRA received a positive opinion by the Swedish Medical Products Agency. Read More »
FDA also grants Orphan Drug Designation for the therapy. Read More »
PDL BioPharma recently announced that its has agreed to a $75 million initial equity investment in Noden Pharma DAC, a privately held company based in Ireland, and an affiliate. Read More »
Opens mobile pharmacy to provide pharmacy services to Elkview residents. Read More »
Cigna and Hill Physicians Medical Group have announced that the two companies have agreed to enter a care program partnership that will put an emphasis on the improvement of patient health while decreasing the cost. Read More »
SPIRE-HR and SPIRE-FH lipid-lowering studies meet primary endpoints. Read More »
Copay increases could affect TRICARE beneficiaries' access to prescriptions. Read More »
Store scheduled to open in the mixed use complex in December. Read More »
Ampio Pharmaceuticals Inc. recently announced the results from its PIVOT clinical trials to access the efficacy and safety of Ampion intra-articular injection among patients who have pain from osteoarthritis (OA) in their knees. Read More »
The agreements allow AstraZeneca to focus on its main therapy areas. Read More »
Patent submitted to the FDA Orange Book for approval on June 28. Read More »
Two software programs to integrate and automate medical reviews and payment authorizations. Read More »
Twenty-year FDA veteran tapped to lead OCE through initial phase. Read More »
Alerts Sign-up
